Last 12 months
Inside the activity.
13 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 9 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 4 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 15, 2021 Filed Dec 17, 2021 14:30 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 100,000 | $3.45 | $345,000.00 |
DisclosureSEC source: 0001214659-21-013314 · marketforms-54703.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,723,989 Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:20 UTC |
ESHELMAN FREDRIC NDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005365 · form4-11222021_061158.xml · derivative · entry 2 ESHELMAN FREDRIC N · CIK 0001033409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:20 UTC |
ESHELMAN FREDRIC NDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005365 · form4-11222021_061158.xml · nonDerivative · entry 1 ESHELMAN FREDRIC N · CIK 0001033409 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,299,750 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:11 UTC |
MARIO ERNESTDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005359 · form4-11222021_061130.xml · derivative · entry 2 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:11 UTC |
MARIO ERNESTDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005359 · form4-11222021_061130.xml · nonDerivative · entry 1 MARIO ERNEST · CIK 0001180469 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,706 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:09 UTC |
LEE KENNETH B JRDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005357 · form4-11222021_061146.xml · derivative · entry 2 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:09 UTC |
LEE KENNETH B JRDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005357 · form4-11222021_061146.xml · nonDerivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,322 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:16 UTC |
SUN ANTHONY YDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005363 · form4-11222021_061140.xml · derivative · entry 2 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:16 UTC |
SUN ANTHONY YDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005363 · form4-11222021_061140.xml · nonDerivative · entry 1 SUN ANTHONY Y · CIK 0001377952 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,322 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:07 UTC |
LaBelle Curt HDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005355 · form4-11222021_061119.xml · derivative · entry 2 LaBelle Curt H · CIK 0001396235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:07 UTC |
LaBelle Curt HDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005355 · form4-11222021_061119.xml · nonDerivative · entry 1 LaBelle Curt H · CIK 0001396235 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,236 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:14 UTC |
MATHER CHARLES E IVDirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005361 · form4-11222021_061107.xml · derivative · entry 2 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 09:14 UTC |
MATHER CHARLES E IVDirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005361 · form4-11222021_061107.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,322 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 14:22 UTC |
Haller Julia ADirector
|
GrantStock Option (right to buy) · Derivative | 9,653 | $0.00 Strike: $3.59 | $0.00 |
DisclosureSEC source: 0001415889-21-005367 · form4-11222021_061159.xml · derivative · entry 2 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,653 Underlying: Common Stock · 9,653 shares Expires 2031-11-17 F2 · derivative.exercise_date: The option becomes exercisable on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 17, 2021 Filed Nov 22, 2021 14:22 UTC |
Haller Julia ADirector
|
GrantCommon Stock, par value $.0001 | 6,963 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-21-005367 · form4-11222021_061159.xml · nonDerivative · entry 1 Haller Julia A · CIK 0001656082 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,186 F1 · shares: Represents restricted stock units that fully vest on the earlier of November 17, 2022 or the date of the Issuer's 2022 annual meeting of stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors and acceleration upon change in control. Read SEC document |
| November 16, 2021 Filed Nov 17, 2021 12:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 25,000 | $3.52 | $88,000.00 |
DisclosureSEC source: 0001214659-21-011937 · marketforms-54266.xml · nonDerivative · entry 4 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,623,989 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 12:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 25,000 | $3.67 | $91,750.00 |
DisclosureSEC source: 0001214659-21-011937 · marketforms-54266.xml · nonDerivative · entry 3 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,598,989 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 12:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 25,000 | $3.64 | $91,000.00 |
DisclosureSEC source: 0001214659-21-011937 · marketforms-54266.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,573,989 Read SEC document |
| November 15, 2021 Filed Nov 17, 2021 12:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 25,000 | $3.60 | $90,000.00 |
DisclosureSEC source: 0001214659-21-011937 · marketforms-54266.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,548,989 Read SEC document |
| November 03, 2021 Filed Nov 3, 2021 23:54 UTC |
Ianchulev TsontchoDirector · CHIEF EXECUTIVE OFFICER
|
PurchaseCommon Stock, par value $.0001 | 30,000 | $4.04 | $121,206.00 |
DisclosureSEC source: 0001415889-21-005059 · form4-11032021_041112.xml · nonDerivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · CHIEF EXECUTIVE OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 579,895 Read SEC document |
| November 01, 2021 Filed Nov 1, 2021 17:05 UTC |
MATHER CHARLES E IVDirector
|
PurchaseCommon Stock, par value $.0001 | 4,000 | $3.83 | $15,314.40 |
DisclosureSEC source: 0001415889-21-005035 · form4-11012021_021155.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,359 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 10:57 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 15,105 | $3.75 | $56,643.75 |
DisclosureSEC source: 0001214659-21-011027 · marketforms-54135.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,539,094 Read SEC document |
| October 29, 2021 Filed Nov 2, 2021 10:57 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 400 | $3.74 | $1,496.00 |
DisclosureSEC source: 0001214659-21-011027 · marketforms-54135.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,523,989 Read SEC document |
| October 27, 2021 Filed Oct 27, 2021 20:02 UTC |
Rowe Michael MCHIEF OPERATING OFFICER
|
PurchaseCommon Stock, par value $.0001 | 1,200 | $4.14 | $4,968.00 |
DisclosureSEC source: 0001415889-21-004985 · form4-10272021_011041.xml · nonDerivative · entry 1 Rowe Michael M · CIK 0001744774 · CHIEF OPERATING OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,500 Read SEC document |
| October 26, 2021 Filed Oct 27, 2021 11:42 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, Par Value $0.0001 | 100,000 | $4.00 | $400,000.00 |
DisclosureSEC source: 0001214659-21-010791 · ownership.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,523,589 Read SEC document |
| October 25, 2021 Filed Oct 27, 2021 11:42 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon stock, par value $0.0001 | 33,806 | $4.00 | $135,224.00 |
DisclosureSEC source: 0001214659-21-010791 · ownership.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,423,589 Read SEC document |
| September 13, 2021 Filed Sep 13, 2021 21:04 UTC |
Rowe Michael MChief Operating Officer
|
PurchaseCommon Stock, par value $.0001 | 1,500 | $4.40 | $6,600.00 |
DisclosureSEC source: 0001638599-21-000708 · doc4_7350.xml · nonDerivative · entry 1 Rowe Michael M · CIK 0001744774 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,300 Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 49,057 | $3.98 | $195,246.86 |
DisclosureSEC source: 0001214659-21-008881 · marketforms-53630.xml · nonDerivative · entry 3 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,389,783 Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 750 | $3.96 | $2,970.00 |
DisclosureSEC source: 0001214659-21-008881 · marketforms-53630.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,340,726 Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 193 | $3.98 | $767.18 |
DisclosureSEC source: 0001214659-21-008881 · marketforms-53630.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339,976 Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 100 | $3.95 | $395.00 |
DisclosureSEC source: 0001214659-21-008807 · marketforms-53620.xml · nonDerivative · entry 4 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339,783 Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 100 | $3.95 | $394.60 |
DisclosureSEC source: 0001214659-21-008807 · marketforms-53620.xml · nonDerivative · entry 3 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339,683 Read SEC document |
| August 18, 2021 Filed Aug 19, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 724 | $3.93 | $2,845.32 |
DisclosureSEC source: 0001214659-21-008807 · marketforms-53620.xml · nonDerivative · entry 2 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,339,583 Read SEC document |
| August 17, 2021 Filed Aug 19, 2021 10:00 UTC |
Grant Stuart M.10% owner
|
PurchaseCommon Stock, par value $.0001 | 23,419 | $4.00 | $93,676.00 |
DisclosureSEC source: 0001214659-21-008807 · marketforms-53620.xml · nonDerivative · entry 1 Grant Stuart M. · CIK 0001783415 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,338,859 Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 11:33 UTC |
Clasby Jennifer GVP, Regulatory and Clinical
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,510 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-21-000589 · doc4_7280.xml · derivative · entry 3 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,510 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: The Employee Stock Option became exercisable as to 2,228 shares on August 7, 2017, and as to 2,228 shares on each of the 35 one-month anniversaries thereafter. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 11:33 UTC |
Clasby Jennifer GVP, Regulatory and Clinical
|
Tax withholdingCommon Stock | 14,262 | $5.42 | $77,300.04 |
DisclosureSEC source: 0001638599-21-000589 · doc4_7280.xml · nonDerivative · entry 2 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,950 Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 11:33 UTC |
Clasby Jennifer GVP, Regulatory and Clinical
|
Exercise / conversionCommon Stock | 24,510 | $1.95 | $47,794.50 |
DisclosureSEC source: 0001638599-21-000589 · doc4_7280.xml · nonDerivative · entry 1 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2021 Filed Jul 21, 2021 12:21 UTC Amendment |
Clasby Jennifer GVP, Regulatory and Clinical
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 24,510 | $0.00 Strike: $1.95 | $0.00 |
DisclosureSEC source: 0001638599-21-000605 · doc4a_7294.xml · derivative · entry 3 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,510 shares Expires 2027-07-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The Employee Stock Option became exercisable as to 2,228 shares on August 7, 2017, and as to 2,228 shares on each of the 35 one-month anniversaries thereafter. Read SEC document |
| June 17, 2021 Filed Jul 21, 2021 12:21 UTC Amendment |
Clasby Jennifer GVP, Regulatory and Clinical
|
Tax withholdingCommon Stock | 13,675 | $5.42 | $74,118.50 |
DisclosureSEC source: 0001638599-21-000605 · doc4a_7294.xml · nonDerivative · entry 2 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,537 F1 · shares: This amendment to the Form 4 is being filed to report an adjustment of 587 shares to the number of shares withheld from the Reporting Person to cover tax obligations, which amount was previously over-withheld due to an administrative error. Read SEC document |
| June 17, 2021 Filed Jul 21, 2021 12:21 UTC Amendment |
Clasby Jennifer GVP, Regulatory and Clinical
|
Exercise / conversionCommon Stock | 24,510 | $1.95 | $47,794.50 |
DisclosureSEC source: 0001638599-21-000605 · doc4a_7294.xml · nonDerivative · entry 1 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,212 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 09:20 UTC |
Clauson LukeVP Research & Development
|
GrantStock Option (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000562 · doc4_7272.xml · derivative · entry 1 Clauson Luke · CIK 0001736840 · VP Research & Development 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 09:21 UTC |
Clasby Jennifer GVP, Regulatory and Clinical
|
GrantStock Option (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000563 · doc4_7271.xml · derivative · entry 1 Clasby Jennifer G · CIK 0001728919 · VP, Regulatory and Clinical 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 09:22 UTC |
GANDOLFO JOHN PChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000565 · doc4_7269.xml · derivative · entry 1 GANDOLFO JOHN P · CIK 0001200155 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 13:22 UTC |
Ianchulev TsontchoDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 139,867 | $6.01 Strike: $6.01 | $840,600.67 |
DisclosureSEC source: 0001638599-21-000566 · doc4_7268.xml · derivative · entry 1 Ianchulev Tsontcho · CIK 0001728916 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 139,867 Underlying: Common Stock · 139,867 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 13:22 UTC |
Rowe Michael MChief Operating Officer
|
GrantStock Options (right to buy) · Derivative | 128,258 | $6.01 Strike: $6.01 | $770,830.58 |
DisclosureSEC source: 0001638599-21-000564 · doc4_7270.xml · derivative · entry 1 Rowe Michael M · CIK 0001744774 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,258 Underlying: Common Stock · 128,258 shares Expires not disclosed F1 · derivative.expiration_date: 1. This stock option was granted by the Issuer's Board of Directors on January 30, 2021, subject to stockholder approval of an amendment to the Issuer's Amended and Restated 2018 Omnibus Stock Incentive Plan (the "Plan"). The Issuer's stockholders approved the amendment to the Plan on June 16, 2021. One-third of the option becomes exercisable on January 30, 2022 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter. Read SEC document |
| June 15, 2021 Filed Jun 15, 2021 16:26 UTC |
LEE KENNETH B JRDirector
|
PurchaseCommon Stock, par value $.0001 | 2,000 | $5.41 | $10,812.00 |
DisclosureSEC source: 0001638599-21-000551 · doc4_7267.xml · nonDerivative · entry 3 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,359 Read SEC document |
| June 14, 2021 Filed Jun 15, 2021 16:26 UTC |
LEE KENNETH B JRDirector
|
PurchaseCommon Stock, par value $.0001 | 2,000 | $5.47 | $10,940.00 |
DisclosureSEC source: 0001638599-21-000551 · doc4_7267.xml · nonDerivative · entry 2 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,359 Read SEC document |
| June 11, 2021 Filed Jun 15, 2021 16:26 UTC |
LEE KENNETH B JRDirector
|
PurchaseCommon Stock, par value $.0001 | 2,000 | $5.38 | $10,760.00 |
DisclosureSEC source: 0001638599-21-000551 · doc4_7267.xml · nonDerivative · entry 1 LEE KENNETH B JR · CIK 0001208570 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,359 Read SEC document |
| May 28, 2021 Filed May 28, 2021 16:09 UTC |
MATHER CHARLES E IVDirector
|
PurchaseCommon Stock, par value $.0001 | 3,000 | $4.76 | $14,268.30 |
DisclosureSEC source: 0001638599-21-000474 · doc4_7224.xml · nonDerivative · entry 1 MATHER CHARLES E IV · CIK 0001563422 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,359 Read SEC document |
| May 27, 2021 Filed May 28, 2021 17:38 UTC |
Rowe Michael MChief Operating Officer
|
PurchaseCommon Stock, par value $.0001 | 1,400 | $4.71 | $6,594.00 |
DisclosureSEC source: 0001638599-21-000472 · doc4_7223.xml · nonDerivative · entry 1 Rowe Michael M · CIK 0001744774 · Chief Operating Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,800 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.